The object of this study was to describe a method of measuring targeting accuracy in functional neurosurgery using MR imaging and the Stereotactic Atlas of the Human Thalamus and Basal Ganglia. This method should be useful for any functional procedure using these tools or similar ones, and is described here in the specific context of focused ultrasound surgery. The authors describe the atlas coordinate system used, the different relevant targeting and accuracy definitions, the tools used, the intraoperative target determination, the postoperative target reconstructions, and the calculation of the therapeutic lesion volume. The proposed method has been applied to the specific situation of measuring targeting accuracy in focused ultrasound functional neurosurgery. The authors found mean absolute global targeting accuracies between 0.54 and 0.72 mm (SDs between 0.34 and 0.42 mm), with 85% of measured coordinates within 1 mm. The proposed method may be particularly useful in the context of functional neurosurgical procedures implying therapeutic ablations, be they through radiofrequency, focused ultrasound, or any other technique. This method allows an ongoing control of the targeting precision, a basic requirement in any functional neurosurgical procedure. 
T he therapeutic application of focused ultrasound in functional neurosurgery requires refined target reconstructions and precise targeting accuracy measurements within the millimeter domain. Because targets are in normal tissue, coordinates have to be established for each target on the basis of a stereotactic atlas of the human brain. Such an atlas uses internal landmarks to position a coordinate system onto the brain, allowing the placement of any desired target inside the brain. We use the Stereotactic Atlas of the Human Thalamus and Basal Ganglia, 1, 2 which provides the following essential qualities better than other atlases (such as the SchaltenbrandWahren): 1) guaranteed proper cutting angles, due to use of a special guillotine; 2) maps drawn every 0.9 mm; 3) use of several histological staining techniques (multiarchitectonic atlas); and 4) an atlas based on a histological experience from 7 human autopsy brains, and consecutive atlas maps drawn from 4 hemispheres.
In functional neurosurgery, 2 steps of the treatment procedure need to be performed with a precision to within 1 mm: 1) the projection, based on the atlas, of the 3 coordinates of a chosen target onto the intraoperative MR imaging; and 2) the determination of the 3D position of the realized therapeutic lesion on postoperative MR imaging. This second step allows the establishment of the targeting accuracy of the entire therapeutic procedure.
Measurement of targeting accuracy in focused ultrasound functional neurosurgery Technical note
The targeting accuracy measurement procedure presented here can be used in any functional neurosurgical setup. It has been developed in the context of a clinical study that has as its goal to provide relief to patients suffering from chronic therapy-resistant functional brain disorders (neuropathic pain, Parkinson disease, and essential tremor) by performing a small therapeutic ablation in or around the thalamus using the ExAblate 4000 Neuro (InSightec, Ltd.). This device allows the transcranial and MR-guided application of focused ultrasound energy into brain tissue. As stated above, this application must be performed with a precision to within 1 mm; that is, the center of the therapeutic lesion must lay a maximum of 1 mm away from the center of the desired target. In the following sections, we will present our targeting accuracy measurement method and then apply it as an example to the analysis of the precision of our first 9 focused ultrasound procedures.
Methods

Atlas Coordinate System
The use of a brain atlas provides a coordinate system independent from the coordinate matrices of the MR and ultrasound systems. The atlas is based on specific chosen neuroanatomical structures serving as landmarks. The neuroanatomical landmarks used in the Stereotactic Atlas of the Human Thalamus and Basal Ganglia 1,2 are the AC and PC. On a midsagittal scan (Fig. 1 upper) , a line passing through the center of these commissures (the ICL) is used to create the axial dorsoventral "zero" plane. The dorsal direction is above this plane and the ventral is below. The PC is used as the "zero" reference for the anteroposterior axis: positive values are anterior to the PC while negative values are posterior to it. On an axial scan ( Fig. 1 lower) , the ICL is drawn passing through the middle of the third ventricle. The mediolateral axes (right and left) are parallel to the lines passing through the centers of the 2 commissures, themselves perpendicular to the ICL. On the atlas maps, the reference grid starts laterally in the zero position in the middle of the ventricle. However, the width of the ventricle can vary significantly from patient to patient. The thalamoventricular border has thus been chosen as the zero (reference) point for the determination of the mediolateral target coordinate (Fig. 1 lower) .
Targets and Accuracies
There are 3 different kinds of targets for each accuracy measurement: the chosen target, based on surgical experience and established in terms of atlas coordinates; the target prescribed in the ExAblate software; and the realized target visible on postoperative MR images. We qualify all targets by the coordinates of their center. We shall call the atlas target the chosen target. Following the atlas-based determination of the position of the target on the intraoperative MR images, we enter its position coordinates in the "Advanced Options" section of the ExAblate software. These MR (RAS) coordinates define the prescribed target. Lastly, the realized target is measured on the MR postoperative examination.
On this basis, we may compute 2 accuracies: the global accuracy, which is defined as the difference between the realized and the atlas target center coordinates; and the device accuracy, which is the difference between the prescribed and the realized target center coordinates, given in millimeters. For the 3 directions (mediolateral, anteroposterior, and dorsoventral), the global accuracy can be computed as the difference between the atlas target and the realized target:
global accuracy = realized target -atlas target.
This global accuracy depends on the precision of many steps during the treatment process. The first relevant step is defined as the planning accuracy, which depends on the reconstruction of the atlas target on the intraoperative MR images. This reconstruction provides the prescribed target center coordinates. The planning accuracy can therefore be obtained as follows:
planning accuracy = prescribed target -atlas target.
This planning accuracy, subtracted from the global accuracy, then gives a device accuracy:
device accuracy = global accuracy -planning accuracy.
From the technical point of view, the device accuracy is the most relevant to define the precision of the targeting of the device itself. It should be noted that this accuracy contains the manual correction (with its own accuracy) that can be applied during the treatment and a If no manual correction is applied during the treatment, it means that: manual correction = manual correction accuracy = 0, the device accuracy is then equal to the technical accuracy.
In the best case, this manual correction should fully compensate for the technical deviation of the device: manual correction + manual correction accuracy = technical accuracy which implies a device accuracy being equal to 0.
This best case strongly depends on the skills of the user to visually estimate the technical deviation of the machine and correct it. Therefore, the device accuracy may be considered as man-as well as machine-based. However, the manual correction (and its accuracy) depends mainly on the quality of the MR thermal maps and is therefore technically related.
Summarizing and simplifying, the 3 accuracies we want to obtain are the global accuracy, the planning accuracy, and the device accuracy:
global accuracy = device accuracy + planning accuracy.
These accuracies can be considered as 3D vectors with their sign (+ or -) for each direction. But the device and planning accuracies should not compensate each other; for example, if a +1 mm difference on a direction is measured for 1 targeting accuracy and a -1 mm difference for the other targeting accuracy in the same direction, the mean will be zero. The mean should, however, be 1 mm, and this is obtained by using the absolute value of the device and planning accuracies.
Measurement Tools
A brief description of the tools used to determine and reconstruct targets is shown in Table 1 . One thing to be noted is that the intraoperative target determination is performed on the MR workstation during the operation while postoperative target reconstructions are conducted on a normal desktop computer (not mentioned in the table).
Magnetic Resonance Imaging
The precision of all target determinations and reconstructions rely on MR imaging. If the 3 orientations are not orthogonal and precisely prescribed, a very significant error in target determination and measurements may happen. All MR series must be performed in the same way as the Stereotactic Atlas 1,2 maps, that is, with the zero axial plane passing through the centers of the AC and PC. A minimum of 2 out of the 3 orientations (axial, sagittal, and coronal) is required to prescribe a target or to perform a target reconstruction. We work mainly with the sagittal and the axial series.
The sagittal scans have to be prescribed on the "3-plane localizer" images, using axial and coronal orientations. Care must be taken to prescribe a precisely midsagittal slice, thus allowing the detailed visualization of the AC and PC. This is performed mainly on a transthalamic 3-plane localizer axial image, and the prescription of the midsagittal slice must pass in the middle of the third ventricle with the proper angle (Fig. 2 right) . The tilt of this plane has to be checked on the coronal 3-plane localizer image (Fig. 2 left) , also adjusting the angle here so that the plane will be strictly midsagittal. The prescription of the axial series then needs to be performed using this midsagittal image and the same coronal 3-plane localizer image. Summing up, the central axial slice has to pass through the centers of the AC and PC (Fig. 3 right) , while its tilt has to follow the patient's head tilt as noted on the coronal images (Fig. 3 left) .
Target Determination
For each operation, the atlas target center coordinates are determined using intraoperative MR T2-weighted FRFSE sagittal and axial series in the following manner: 1) choose 2-mm slice thickness, 0-mm gap MR images using the procedure described above; 2) locate the slice containing the 2 commissures (AC and PC) on the axial series using the GE viewer software; 3) draw the ICL; 4) perpendicularly to this line (angle tool) draw 2 parallel lines in the middle of each commissure and a third one through the midcommissural point; 5) copy these lines on all slices of the series; 6) browse the MR axial slices dorsal or ventral depending on the dorsoventral position of the target; 7) determine the anteroposterior position of the target on the ICL and draw a line through this position and parallel to the ones passing through the centers of the AC and PC (the anteroposterior target coordinate is positioned in relation to 1 of the 3 landmarks-AC, PC, or midcommissural point-that is closest to the target, with the goal of reducing the effect of interindividual variability); 8) from the thalamoventricular border, go laterally on this line to the target position; and 9) note the RAS coordinates of this point, representing the atlas target now translated into RAS coordinates. In our setup, these coordinates are entered into the "Advanced Options" section of the ExAblate software.
Target Reconstructions
The position of the center of the realized target is determined on postoperative MR T2-weighted FRFSE sagittal and axial series in essentially the same manner as for the target determination: 1) choose 2-mm thickness, 0-mm gap MR slices of the thalamus, produce a strict midsagittal slice and then an axial dorsoventral zero slice passing precisely through the center of the AC and PC, as described in the imaging procedure above; 2) on the dorsoventral zero slice, draw the ICL; 3) perpendicularly to this line ("angle tool") draw 2 parallel lines in the middle of each commissure and a third one through the midcommissural point; 4) copy these lines on all slices of the series; 5) locate the axial slice where the realized target is the most visible and the largest; 6) draw a line that is parallel to the ones passing through the centers of the 2 commissures and that passes through the center of the realized target, and measure the distance between the thalamoventricular border and the center of the realized target, thus obtaining the mediolateral target position (Fig. 4); 7) on the ICL, measure the distance between 1 of the 3 landmarks-AC, PC, or midcommissural point-that is closest to the realized target and the line passing through its center, thus obtaining the anteroposterior target position (Fig. 4); 8) draw the ICL on the midsagittal slice, passing through the center of the 2 commissures; 9) copy this line on all slices of the series; 10) locate the sagittal slice where the realized target is the most visible and the largest; and 11) perpendicularly to the ICL (angle tool), measure the distance between the ICL and the estimated center of the realized target, thus obtaining the dorsoventral target position.
To check the accuracy of the placement of the target into the ExAblate software (blue circle on Fig. 5) , we proceed in our setup to the "Replay Mode" of the ExAblate workstation. This process is nearly the same as for the reconstruction of the center of the realized target: 1) on the "Replay Mode," select the "planning" images; 2) locate the axial slice containing the dorsoventral zero plane; 3) draw the ICL; 4) perpendicularly to this line draw 2 parallel lines through the middle of each commissure (AC and PC) and a third one through the midcommissural point; 5) copy these lines on the image where the blue circle representing the prescribed target is best seen; 6) draw a line that is parallel to those passing through the centers of the 2 commissures and that passes through the center of the prescribed target, and measure the distance between the thalamoventricular border and the center of the prescribed target, thus obtaining the mediolateral target position (Fig. 5) ; 7) on the ICL, measure the distance between 1 of the 3 landmarks-AC, PC, or midcommissural point-that is closest to the prescribed target and the line passing through its center, obtaining thus the anteroposterior target position (Fig. 5) ; 8) draw the ICL on the midsagittal slice, passing through the center of the 2 commissures; 9) copy this line on the image where the blue rectangle representing the prescribed target is best seen; and 10) perpendicularly to the ICL, measure the distance between the ICL and the center of the prescribed target, thus obtaining the dorsoventral target position.
Estimated Volume of the Lesion
On all axial scans (in general 3) in which the realized target is visible, determine its diameters (measure 2 perpendicular diameters and take the mean; Fig. 6A-C) . On T2-weighted images, the lesion with its center and crown can be relatively easily differentiated from the surrounding vasogenic edema, which is less hyperdense.
On the sagittal scan in which the realized target is the largest, measure its height (Fig. 6D) . The volume of the realized target can then be computed as the sum of the volume of 2 truncated cones: in which h is the height of the realized target and r 1 , r 2 , and r 3 are the mean radii of the realized target.
Results
As an illustration of the described procedure, Figures 7 and 8 display the targeting accuracy measurements for our first 9 focused ultrasound treatments, comprising 11 reconstructed realized targets. Figure 7 shows the obtained absolute global accuracies, including means and SDs. In more than 33 measured coordinates, 5 (15.2%) exceed 1 mm (maximum 1.7 mm). The mean value for each of the 3 directions is comprised inside 1 mm: 0.54 ± 0.34 mm for the anteroposterior direction and 0.72 mm for both the mediolateral and dorsoventral directions (± 0.42 and 0.39 mm, respectively). Figure 8 shows the computed planning and device accuracies.
Discussion
In the last 22 years our group has, as a routine, developed and applied target accuracy controls based on the Stereotactic Atlas of the Human Thalamus and Basal Ganglia. 1, 2 This was warranted by our choice to perform selective small ablations based on pathophysiological evidence. We hope that the procedure presented here will be considered useful by colleagues and groups initiating their experience with therapeutic ablations using focused ultrasound.
We would like to stress here the importance of 2 factors contributing to an adequate measurement of targeting accuracy: 1) the proper alignment of the collection of MR imaging slices used with correction of tilts and rotations, particularly relevant for lateral targets; and 2) the necessity of a high-resolution visualization of the 2 commissures, allowing a refined determination of their centers under a high magnification. In our experience, the described T2-weighted imaging without 3D reformatting has been the best option, for both postoperative imaging using a 32-channel head coil, but also for intraoperative imaging using the body coil of the GE Discovery MR 750 system.
Although our experience is relatively small, using the described procedure in this paper we demonstrated that 84.8% of our targeted coordinates lie within 1 mm, providing a mean targeting accuracy of the focused ultrasound treatment of 0.72 mm maximum, thus fulfilling the basic criterion of an accuracy inside 1 mm. Such an accuracy requirement obeys clinical efficiency and safety criteria, and is globally compatible with the limitations of the target reconstruction procedure, primarily manual measurements on MR images, thickness of the MR slices (2 mm), lesion size (4 × 4 × 6 mm), and determination of the lesion center. Future technological developments can be expected to contribute to an even more precise targeting, but also increased experience, considering the particular importance of human decision-making for an optimized treatment process. 
